Total trials
193
Active
40
Phase 3
3
Total enrollment
105,858
Pipeline matrix
Showing 8 of 8 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Picoprep | — | — | — | — | — | 1 | |
| Plenvu | — | — | — | — | — | 1 | |
| Lithium | — | — | — | — | — | 1 | |
| Cariprazine | — | — | — | — | — | 1 | |
| [68Ga]Ga-FAPI-46 PET/CT | — | — | — | — | — | 1 | |
| Local and systemical treatment | — | — | — | — | — | 1 | |
| Iodine-based contrast agent | — | — | — | — | — | 1 | |
| Gadolinium-based contrast agent | — | — | — | — | — | 1 |
Next readouts
- 2024-10-31
- 2025-12-01
- 2027-04-30
- 2028-03-21
- 2028-09-01
Top conditions
- Colorectal Cancer4
- Low Back Pain4
- BPPV4
- Recurrent Pregnancy Loss4
- Oxygen Toxicity3
- Pulmonary Embolism3
- Habitual Abortion3
- Accidental Fall3
Frequently asked questions about Aalborg University Hospital
- How many clinical trials does Aalborg University Hospital have on ClinicalTrials.gov?
- Aalborg University Hospital is listed as the lead sponsor on 193 clinical trials in ClinicalTrials.gov, 40 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Aalborg University Hospital's trials are in Phase 3?
- 3 of Aalborg University Hospital's trials are in Phase 3, spread across 8 active drug programs.
- What therapeutic areas does Aalborg University Hospital focus on?
- Aalborg University Hospital's most-studied conditions on ClinicalTrials.gov are Colorectal Cancer, Low Back Pain, BPPV, Recurrent Pregnancy Loss, Oxygen Toxicity.
- When are Aalborg University Hospital's next clinical trial readouts?
- Aalborg University Hospital has 5 upcoming primary-completion readouts tracked here; the soonest is “Incidence of Macular Edema in a Uveitis Population”, expected around 2024-10-31.